Nanobiotix(NBTX) - 2023 Q3 - Earnings Call Presentation

• Cash balance as of September 30, 2023: €38.7 million • Closing of recent financing result(ed) in gross proceeds of €50.9 million • EIB cash covenant removed • This excludes any further dilutive (incl. use of equity line) or non-dilutive financing, and includes a first de- risked milestones from NBTXR3 collaboration • Cash Runway is expected to extend to end of Q2 25 upon completion of remaining amount of €4.6 million of €23.7 million ($25 million) second tranche commitment of JJDC, subject to closing cond ...